University of Texas Medical Branch
Rheumatology fellowship · Galveston, TX · Program website
This program's roster hasn't been collected yet, so there's no list of its own faculty and papers. Below is The University of Texas Medical Branch at Galveston's research in rheumatology, which the program shares with other departments and affiliated hospitals.
About The University of Texas Medical Branch at Galvestoninstitution-wide rheumatology research
Rheumatology publications from The University of Texas Medical Branch at Galveston and affiliated institutions, since 2022. Updated 2026-11-06; refreshed daily.
25
works per year
32nd of 60 rheumatology fellowship programs
+30.2%
2-year growth
15th of 60 rheumatology fellowship programs
14.5%
in top 10% of field (works before 2025)
37th of 54 rheumatology fellowship programs
30.6%
cited above world average
44th of 54 rheumatology fellowship programs
Works per year · * 2026 so far
Rheumatology · 120
Rheumatology research topics at The University of Texas Medical Branch at Galveston
Papers in the window; each links to the list on OpenAlex.
- Systemic Lupus Erythematosus Research 48
- Pelvic floor disorders treatments 25
- Osteoarthritis Treatment and Mechanisms 10
- Folate and B Vitamins Research 5
- Bone Tumor Diagnosis and Treatments 4
- Soft tissue tumor case studies 4
- Heterotopic Ossification and Related Conditions 4
- Dupuytren's Contracture and Treatments 4
Most cited at The University of Texas Medical Branch at Galveston since 2024
All rheumatology papers there on OpenAlex
- Deciphering the clinical significance of longitudinal antiphospholipid antibody titersCecilia Beatrice Chighizola et al. · Autoimmunity Reviews · 2024 · PubMed · cited 15
- A proteomic map of thromboinflammatory signatures in antiphospholipid syndrome: results from antiphospholipid syndrome alliance for clinical trials and international networking (APS ACTION) registryAlexander B. Pine et al. · Frontiers in Immunology · 2025 · PubMed · cited 12
- Osteochondral Allograft Reaming Significantly Affects Chondrocyte ViabilityTristan J. Elias et al. · The American Journal of Sports Medicine · 2024 · PubMed · cited 12
- ANA-positive versus ANA-negative Antiphospholipid Antibody-positive Patients: Results from the Antiphospholipid Syndrome Alliance for Clinical Trials and International Networking (APS ACTION) Clinical Database and Repository (“Registry”)Irene Cecchi et al. · Rheumatology · 2024 · PubMed · cited 11
- 2023 American College of Rheumatology/European League Against Rheumatism antiphospholipid syndrome classification criteria solid phase–based antiphospholipid antibody domain—collaborative efforts of Antiphospholipid Syndrome Alliance for Clinical Trials and International Networking and ISTH SSC to harmonize enzyme-linked immunosorbent assay and non–enzyme-linked immunosorbent assay antiphospholipid antibody tests: communication from the ISTH SSC Subcommittee on Lupus Anticoagulant/Antiphospholipid AntibodiesPier Luigi Meroni et al. · Journal of Thrombosis and Haemostasis · 2024 · PubMed · cited 11
- Predictors of Mortality in Antiphospholipid Antibody–Positive Patients: Prospective Results From Antiphospholipid Syndrome Alliance for Clinical Trials and International Networking Clinical Database and RepositoryYasaman Ahmadzadeh et al. · Arthritis Care & Research · 2025 · PubMed · cited 8
- Optimizing Patient Outcomes Following Osteochondral Allograft Transplantation: The Impact of 25 Years of Translational and Clinical ResearchBrian J. Cole et al. · Journal of Orthopaedic Research® · 2025 · PubMed · cited 5
- Clinical and biologic predictors of thrombosis in persistently antiphospholipid antibody-positive patients: Prospective analysis of the International APS ACTION Clinical Database and Repository (‘Registry’)Jonathan Thaler et al. · Annals of the Rheumatic Diseases · 2025 · PubMed · cited 4
- Protective Role of Dietary Short-Chain Fatty Acid Propionate against Autoimmune Responses and Pathology of Systemic Lupus Erythematosus in MRL-lpr MiceHui Wang et al. · Journal of Nutrition · 2025 · PubMed · cited 4
- Development of the 2023 ACR/EULAR Antiphospholipid Syndrome Classification Criteria, Phase III‐D Report: Multicriteria Decision AnalysisMedha Barbhaiya et al. · Arthritis Care & Research · 2024 · PubMed · cited 4